REVBW (Revelation Biosciences, Inc. Warrant)
Insider Trading Activity
Every open-market purchase and sale reported by REVBW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | James Rolke | Chief Executive Officer | F | — | — |
| 2026-05-01 | Chester Stanley Zygmont III | Chief Financial Officer | F | — | — |
| 2026-02-05 | JENNIFER CARVER | Director | F | — | — |
| 2026-02-05 | Chester Stanley Zygmont III | Chief Financial Officer | F | — | — |
| 2026-02-05 | James Rolke | Chief Executive Officer | F | — | — |
| 2026-02-05 | Lakhmir S Chawla | Director | F | — | — |
| 2026-02-05 | JESS ROPER | Director | F | — | — |
| 2026-01-12 | JESS ROPER | Director | A | — | — |
| 2026-01-12 | Chester Stanley Zygmont III | Chief Financial Officer | A | — | — |
| 2026-01-12 | James Rolke | Chief Executive Officer | A | — | — |
| 2026-01-12 | JENNIFER CARVER | Director | A | — | — |
| 2026-01-12 | Lakhmir S Chawla | Director | A | — | — |
| 2025-10-31 | James Rolke | Chief Executive Officer | A | — | — |
| 2025-10-31 | Chester Stanley Zygmont III | Chief Financial Officer | A | — | — |
| 2025-10-31 | JENNIFER CARVER | Director | A | — | — |
| 2025-10-31 | Lakhmir S Chawla | Director | A | — | — |
| 2025-10-31 | JESS ROPER | Director | A | — | — |
| 2025-02-13 | JESS ROPER | Director | A | — | — |
| 2025-02-13 | Chester Stanley Zygmont III | Chief Financial Officer | A | — | — |
| 2025-02-13 | JENNIFER CARVER | Director | A | — | — |
| 2025-02-13 | Lakhmir S Chawla | Director | A | — | — |
| 2025-02-13 | James Rolke | Chief Executive Officer | A | — | — |
| 2025-02-13 | GEORGE F TIDMARSH | Director | A | — | — |
| 2023-12-12 | GEORGE F TIDMARSH | Director | Sell | — | — |
| 2023-10-18 | GEORGE F TIDMARSH | Director | Sell | — | — |
| 2023-10-17 | GEORGE F TIDMARSH | Director | Sell | — | — |
| 2023-10-02 | GEORGE F TIDMARSH | Director | Sell | — | — |
| 2023-09-18 | GEORGE F TIDMARSH | Director | Sell | — | — |
| 2023-04-19 | GEORGE F TIDMARSH | Director | Buy | — | — |
| 2023-04-18 | GEORGE F TIDMARSH | Director | A | — | — |
| 2023-04-18 | Curt H LaBelle | Director | A | — | — |
| 2023-04-18 | JENNIFER CARVER | Director | A | — | — |
| 2023-04-18 | JESS ROPER | Director | A | — | — |
| 2023-02-28 | James Rolke | Chief Executive Officer | A | — | — |
| 2023-02-28 | Chester Stanley Zygmont III | Chief Financial Officer | A | — | — |
| 2022-02-28 | GEORGE F TIDMARSH | Director | Buy | — | — |
| 2022-02-10 | GEORGE F TIDMARSH | Director | Buy | — | — |
| 2022-02-09 | GEORGE F TIDMARSH | Director | Buy | — | — |
| 2022-02-08 | GEORGE F TIDMARSH | Director | Buy | — | — |
| 2022-01-11 | Lawrence Feis | 10%+ Owner | J | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 214,738 | — |
| — | Chief Financial Officer | 92,063 | — |
| — | Director | 12,828 | — |
| — | Director | 12,758 | — |
| — | Director | 12,158 | — |
| — | Director | 268 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the REVBW quote page; the site-wide leaderboard is on the insider transactions hub.